[TAME]-esterase--a new cardiovascular risk factor in smokers

Area of Science:

• Biochemistry
• Hematology
• Mathematical Modeling

Background:

• Blood clotting is a complex process involving multiple factors.
• Plasma esterase activity, particularly with p-toluenesulfonyl-L-arginine methyl ester (TAME) esterase, is implicated in coagulation.
• Smokers exhibit altered coagulation profiles, potentially increasing thrombotic risk.

Purpose of the Study:

• To investigate the effect of TAME esterase on blood clotting time using a mathematical model.
• To explore the potential role of TAME esterase in the coagulation cascade.
• To assess if increased TAME esterase activity is a risk factor for cerebrovascular accidents in smokers.

Main Methods:

• Development and application of a mathematical model to simulate blood clotting.
• Analysis of plasma TAME esterase activity in a cohort of smokers.
• Correlation of TAME esterase levels with blood clotting time.

Main Results:

• A mathematical model demonstrated a dose-dependent relationship between TAME esterase activity and clotting time.
• Blood clotting time decreased by 30% with increasing plasma TAME esterase activity in smokers.
• A potential link between TAME esterase, Hageman factor, and blood coagulation was suggested.

Conclusions:

• TAME esterase is implicated in the blood coagulation cascade.
• Elevated TAME esterase activity may serve as an additional risk factor for cerebrovascular events in smokers.
• Further research is needed to fully elucidate the mechanism of TAME esterase in clotting.